Национальные рекомендации по ишемической болезни сердца 2016

1. Руководство по кардиологии. Под ред. акад. Е.И.Чазова. В 4
томах. Москва, Издательский дом «Практика» 201.

2. Карпов Ю.А., Сорокин Е.В. «Стабильная ишемическая болезнь
сердца: стратегия и тактика лечения». 2-е изд, перераб. и доп. – Москва,
Медицинское информационное агентство, 2012.- 271.

3. Карпов Ю.А., Кухарчук В.В., Лякишев А.А., Лупанов В.П.,
Панченко Е.П., Комаров А.Л., Ежов М.В., Ширяев А.А., Самко А.Н.,
Соболева Г.Н., Сорокин Е.В. «Диагностика и лечение хронической
ишемической болезни сердца (Практические рекомендации). Кардиологический
вестник 2015; № 3: 3-33.

4. «Кардиология: национальное руководство» под ред. Е.В.Шляхто —
2-е изд., перераб. и доп.- М.: ГЭОТАР-Медиа, 2015.-800 с.

5. Campeau L. Letter: «Grading of angina pectoris». Circulation
1976; 54: 522-523.

6. Montalescot G., Sechtem U., Achenbach S.et al. «2013 ESC
guidelines on the management of stable coronary artery disease: the Task
Force on the management of stable Coronary artery disease of European
Society of Cardiology». Eur Heart J 2013; 34, 2949-3003.

7. Piepoli M.F., Hoes A.W., Stefan Agewall S., et al. «2016
European Guidelines on cardiovascular disease prevention in clinical
practice. The Sixth Joint Task Force of the European Society of
Cardiology and Other Societies on Cardiovascular Disease Prevention in
Clinical in Clinical Practice». European Heart Journal doi:10.
1093/eurheart/ehw106;

8. Кухарчук В.В., Коновалов Г.А., Сусеков А.В, и соавт
«Диагностика и коррекция нарушений липидного обмена с целью профилактики
и лечения атеросклероза». Атеросклероз и дислипидемии 2012; 2: 5-35;

9. Catapano A.L., Graham I., De Backer G., et al «2016 ESC/EAS
Guidelines for the management of dyslipidaemias». Eur Heart J 2016;
doi: 10.1093/eurheartj/ehw272;

10. Лупанов В.П. «Современная стратегия, тактика ведения и
прогноз пациентов со стабильной ишемической болезнью сердца».
Кардиоваскулярная терапия и профилактика. 2016; 15(1): 77-83.

11. «Справочник по медикаментозному лечению сердечно-сосудистых
заболеваний». Под ред. академика Е.И. Чазова. М., “Практика”, 2015.- 320
с.

12. «Рациональная фармакотерапия сердечно-сосудистых заболеваний:
руководство для практикующих врачей» под общ. ред. Е.И.Чазова, Ю.А.
Карпова. — 2-е изд., испр. и доп. -М.: Литтерра, 2014.с 28-36.

13. Spertus JA, Salisbury AC, Jones PG, Conaway DG, Thompson RC.
Predictors of quality-of-life benefit after percutaneous coronary
intervention. Circulation 2004; 110(25):3789–3794.

14. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C,
Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh
BJ, Gitt AK, ESC/EACTS Guidelines 2613 Downloaded from
https://academic.oup.com/eurheartj/article-abstract/35/37/2541/581070 by
guest on 08 December 2017 HulotJS, Marx N, Opie LH, PfistererM,
PrescottE, RuschitzkaF, Sabate M, Senior R, Taggart DP, van der Wall EE,
Vrints CJ, Zamorano JL, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton
C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J,
Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF,
Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W,
Windecker S, Valgimigli M, Claeys MJ, Donner-Banzhoff N, Frank H,
Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Husted
S, James SK, Kervinen K, Kristensen SD, Maggioni AP, Pries AR, Romeo F,
Ryden L, Simoons ML, Steg PG, Timmis A, Yildirir A. 2013 ESC guidelines
on the management of stable coronary artery disease: The Task Force on
the management of stable coronary artery disease of the European Society
of Cardiology. Eur Heart J 2013;34(38):2949–3003

15. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t
Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN,
MacCarthy PA, Fearon WF, Investigators FS. Fractional flow reserve vs.
angiography for guiding percutaneous coronary intervention. N Engl J Med
2009;360(3):213–224.

16. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech
JW, van’t Veer M, Bar F, Hoorntje J,KoolenJ, WijnsW, de Bruyne B.
Percutaneous coronary intervention of functionally nonsignificant
stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol
2007;49(21):2105–2111.

17. Botman KJ, Pijls NH, Bech JW, Aarnoudse W, Peels K, van
Straten B, Penn O, Michels HR, Bonnier H, Koolen JJ. Percutaneous
coronary intervention or bypass surgery in multivessel disease? A
tailored approach based on coronary pressure measurement. Catheter
Cardiovasc Interv 2004;63(2):184–191.

18. TothG,De Bruyne B,Casselman F, DeVroey F, PyxarasS, Di
SerafinoL,VanPraetF, Van Mieghem C, Stockman B, Wijns W, Degrieck I,
Barbato E. Fractional flow reserve-guided vs. angiography-guided
coronary artery bypass graft surgery. Circulation
2013;128(13):1405–1411.

19. Denvir MA, Pell JP, Lee AJ, Rysdale J, Prescott RJ, Eteiba H,
Walker A, Mankad P, Starkey IR. Variations in clinical decision-making
between cardiologists and cardiac surgeons; a case for management by
multidisciplinary teams? J Cardiothorac Surg 2006;1:2

20. Windecker S, Kolh P, Alfonso F, Collet J-P, Cremer J, Falk V,
Filippatos G, Hamm C, Head Stuart J, Jüni P, Kappetein A.P, Kastrati A,
Knuuti J, Landmesser U, Laufer G, Neumann F-J, Richter D.J, Schauerte P,
Sousa Uva M, Stefanini G.G, Taggart D.P, Torracca L, Valgimigli M, Wijns
W, Witkowski A.. 2014 ESC/EACTS Guidelines on myocardial
revascularization. Eur Heart Journal 2014;38, 2541-2619.

21. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T,
Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti
L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL,
Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D,
Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G,
Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z,
Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Alfieri O,
Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G, Vouhe P, von
Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ, Atalar
E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R,
Garot J, Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V,
Nashef SA, Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ,
Pirk J, Rozenman Y, SabateM, StarcR,Thielmann M,Wheatley DJ,Windecker S,
Zembala M.Guidelines on myocardial revascularization: The Task Force on
Myocardial Revascularization of the European Society of Cardiology (ESC)
and the European Association for Cardio-Thoracic Surgery (EACTS). Eur
Heart J 2010;31(20):2501–2555.

22. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE.
Coronary artery bypass graft surgery vs.percutaneous interventions in
coronary revascularization: a systematic review. JAMA
2013;310(19):2086–2095.

23. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA,
Piroth Z, Jagic N, Mobius-Winkler S, Rioufol G, Witt N, Kala P,
MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee
P, Frobert O, Curzen N, Johnson JB, Juni P, Fearon WF, Investigators FT.
Fractional flow reserve-guided PCI vs. medical therapy in stable
coronary disease. N Engl J Med 2012;367(11): 991–1001.

24. Coronary angioplasty vs. medical therapy for angina: the
second Randomised Intervention Treatment of Angina (RITA-2) trial.
RITA-2 trial participants. Lancet 1997; 350(9076):461–468.

25. TIME Investigators. Trial of invasive vs. medical therapy in
elderly patients with chronic symptomatic coronary-artery disease
(TIME): a randomised trial. Lancet 2001;358(9286):951–957.

26. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk
WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L,
Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER,
Spertus JA, Berman DS, Mancini GB, Weintraub WS, Group CTR. Optimal
medical therapy with or without PCI for stable coronary disease. N Engl
J Med 2007;356(15):1503–1516.

27. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W,
Buser PT, Dubach P, Resink TJ, Pfisterer M. Effects of percutaneous
coronary interventions in silent ischemia after myocardial infarction:
the SWISSI II randomized controlled trial. JAMA 2007;297(18):1985–1991.

28. FryeRL, AugustP, BrooksMM, Hardison RM, KelseySF,
MacGregorJM, OrchardTJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA,
Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. A randomized trial of
therapies for type 2 diabetes and coronary artery disease. N Engl J Med
2009;360(24):2503–2515.

29. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC,
Favarato D, Rocha AS, Hueb AC, Ramires JA. Ten-year follow-up survival
of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized
controlled clinical trial of 3 therapeutic strategies for multivessel
coronary artery disease. Circulation 2010; 122(10):949–957.

30. Wijeysundera HC, Nallamothu BK, Krumholz HM, Tu JV, Ko DT.
Meta-analysis: effects of percutaneous coronary intervention vs. medical
therapy on angina relief. Ann Intern Med 2010;152(6):370–379.

31. Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, Shaw RE,
Bangalore S. Percutaneous coronary intervention vs. optimal medical
therapy in stable coronary artery disease: a systematic review and
meta-analysis of randomized clinical trials. Circ Cardiovasc Interv
2012;5(4):476–490.

32. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy
JW, Davis K, Killip T, Passamani E, Norris R et al. Effect of coronary
artery bypass graft surgery on survival: overview of 10-year results
from randomised trials by the Coronary Artery Bypass Graft Surgery
Trialists Collaboration. Lancet 1994;344(8922):563–570.

33. Bittl JA, He Y, Jacobs AK, Yancy CW, Normand SL. Bayesian
methods affirm the use of percutaneous coronary intervention to improve
survival in patients with unprotected left main coronary artery disease.
Circulation 2013;127(22):2177–2185.

34. Dzavik V, Ghali WA, Norris C, Mitchell LB, Koshal A, Saunders
LD, Galbraith PD, Hui W, FarisP, Knudtson ML. Long-term survival in
11,661 patients with multivessel coronary artery disease in the era of
stenting: a report from the Alberta Provincial Projectfor Outcome
AssessmentinCoronary HeartDisease(APPROACH) Investigators. Am Heart J
2001;142(1):119–126.

35. Smith PK, Califf RM, Tuttle RH, Shaw LK, Lee KL, Delong ER,
Lilly RE, Sketch MH Jr., Peterson ED, Jones RH. Selection of surgical or
percutaneous coronary intervention provides differential longevity
benefit. Ann Thorac Surg 2006;82(4):1420–1428; discussion 1428–1429.

36. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A,
Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H,
Ferrazzi P, Petrie MC, O’Connor CM, Panchavinnin P, She L, Bonow RO,
Rankin GR, Jones RH, Rouleau JL. Coronary-artery bypass surgery in
patients with left ventricular dysfunction. N Engl J Med
2011;364(17):1607–1616.

37. Hannan EL, Samadashvili Z, Cozzens K, Walford G, Jacobs AK,
Holmes DR Jr., Stamato NJ, Gold JP, Sharma S, Venditti FJ, Powell T,
King SB 3rd. Comparative outcomes for patients who do and do not undergo
percutaneous coronary intervention for stable coronary artery disease in
New York. Circulation 2012;125(15): 1870–1879.

38. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR,
Higgins RS, Carlson RE, Jones RH. Drug-eluting stents vs.
coronary-artery bypass grafting in multivessel coronary disease. N Engl
J Med 2008;358(4):331–341.

39. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD,
Schaff H, Taylor HA, Chaitman BR. Comparison of surgical and medical
group survival in patients with left main equivalent coronary artery
disease. Long-term CASS experience. Circulation 1995; 91(9):2335–2344.

40. Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M,
Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL, Bypass Angioplasty
Revascularization Investigation 2 Diabetes Study G. The Bypass
Angioplasty Revascularization Investigation 2 Diabetes randomized trial
of different treatment strategies in type 2 diabetes mellitus with
stable ischemic heart disease: impact of treatment strategy on cardiac
mortality and myocardial infarction. Circulation 2009;
120(25):2529–2540.

41. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized
trial of coronary artery bypass surgery. Survival of patients with a low
ejection fraction. N Engl J Med 1985; 312(26):1665–1671.

42. Jones RH, Kesler K, Phillips HR 3rd, Mark DB, Smith PK,
Nelson CL, Newman MF, Reves JG, Anderson RW, Califf RM. Long-term
survival benefits of coronary artery bypass grafting and percutaneous
transluminal angioplasty in patients with coronary artery disease. J
Thorac Cardiovasc Surg 1996;111(5):1013–1025.

43. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA.
Management of heart failure. III. The roleof revascularization in the
treatment of patients with moderate or severe left ventricular systolic
dysfunction. JAMA 1994;272(19): 1528–1534.

44. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE,
Friedman JD, Hayes SW, Cohen I, Germano G, Berman DS. Impact of
ischaemia and scar on the therapeutic benefit derived from myocardial
revascularization vs. medical therapy among patients undergoing
stress-rest myocardial perfusion scintigraphy. Eur Heart J
2011;32(8):1012–1024.

45. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan
PM, Weintraub WS, O’Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman
J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ,
Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK,
Boden WE, Investigators C. Optimal medical therapy with or without
percutaneous coronary intervention to reduce ischemic burden: results
from the Clinical Outcomes Utilizing Revascularization and Aggressive
Drug Evaluation (COURAGE) trial nuclear substudy. Circulation
2008;117(10):1283–1291.

46. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS.
Comparison of the short-term survival benefit associated with
revascularization compared with medical therapy in patients with no
prior coronary artery disease undergoing stress myocardial perfusion
single photon emission computed tomography. Circulation
2003;107(23):2900–2907

47. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL,
Geller N, Sopko G, Pratt C, Deanfield J, Conti CR. Asymptomatic Cardiac
Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients
randomized to initial strategies of medical therapy vs.
revascularization. Circulation 1997;95(8):2037–2043.

48. Bangalore S, Pursnani S, Kumar S, Bagos PG. Percutaneous
coronary intervention vs. optimal medical therapy for prevention of
spontaneous myocardial infarction in subjects with stable ischemic heart
disease. Circulation 2013;127(7):769–781.

49. Katritsis DG, Ioannidis JP. Percutaneous coronary
intervention vs. conservative therapy in nonacute coronary artery
disease: a meta-analysis. Circulation 2005; 111(22):2906–2912.

50. Schomig A, Mehilli J, de Waha A, Seyfarth M, Pache J,
Kastrati A. A meta-analysis of 17 randomized trials of a percutaneous
coronary intervention-based strategy in patients with stable coronary
artery disease. J Am Coll Cardiol 2008;52(11): 894–904.

51. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK,
Kent DM. Percutaneous coronary interventions for non-acute coronary
artery disease: a quantitative 20-year synopsis and a network
meta-analysis. Lancet 2009;373(9667):911–918.

52. Thomas S, Gokhale R, Boden WE, Devereaux PJ. A meta-analysis
of randomized controlled trials comparing percutaneous coronary
intervention with medical therapy in stable angina pectoris. Can J
Cardiol 2013;29(4):472–482.

53. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The
impact of revascularization on mortality in patients with nonacute
coronary artery disease. Am J Med 2009;122(2):152–161.

54. Kapoor JR, Gienger AL, Ardehali R, Varghese R, Perez MV,
Sundaram V, McDonald KM, Owens DK, Hlatky MA, Bravata DM. Isolated
disease of the proximal left anterior descending artery comparing the
effectiveness of percutaneous coronary interventions and coronary artery
bypass surgery. JACC Cardiovasc Interv 2008;1(5):483–491.

55. Aziz O, Rao C, Panesar SS, Jones C, Morris S, Darzi A,
Athanasiou T. Meta-analysis of minimally invasive internal thoracic
artery bypass vs. percutaneous revascularisation for isolated lesions of
the left anterior descending artery. BMJ 2007;334(7594): 617.

56. Blazek S, Holzhey D, Jungert C, Borger MA, Fuernau G, Desch
S, Eitel I, de Waha S, Lurz P, Schuler G, Mohr FW, Thiele H. Comparison
of bare-metal stenting with minimally invasive bypass surgery for
stenosis of the left anterior descending coronary artery: 10-year
follow-up of a randomized trial. JACC Cardiovasc Interv 2013; 6(1):
20–26.

57. Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E,
Walther T, Mohr FW, Schuler G, Falk V. Randomized comparison of
minimally invasive direct coronary artery bypass surgery vs.
sirolimus-eluting stenting in isolated proximal left anterior descending
coronary artery stenosis. J Am Coll Cardiol 2009;53(25):2324–2331.

58. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Stahle E,
Colombo A, Mack MJ, Holmes DR Jr., Morel MA, Van Dyck N, Houle VM,
Dawkins KD, Serruys PW. Coronary artery bypass graft surgery vs.
percutaneous coronary intervention in patients with three-vessel disease
and left main coronary disease: 5-year follow-up of the randomised,
clinical SYNTAX trial. Lancet 2013;381(9867):629–638.

59. Capodanno D, Stone GW, Morice MC, Bass TA, Tamburino C.
Percutaneous coronary intervention vs. coronary artery bypass graft
surgery in left main coronary artery disease: a meta-analysis of
randomized clinical data. J Am Coll Cardiol 2011; 58(14):1426–1432.

60. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR,
Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N,
Leadley K, Dawkins KD, Mohr FW. Percutaneous coronary intervention vs.
coronary-artery bypass grafting for severe coronary artery disease. N
Engl J Med 2009;360(10): 961–972.

61. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack
M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ,
Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE,
Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S,
King S 3rd, Bertrand M, Fuster V, Investigators FT. Strategies for
multivessel revascularization in patients with diabetes. N Engl J Med
2012;367(25):2375–2384.

62. Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A,
Mack MJ, Morice MC, Holmes DR, Feldman TE, Staehle E, Underwood P,
Dawkins KD, Kappetein AP, Mohr FW. Coronary artery bypass grafting vs.
percutaneous coronary intervention for patients with three-vessel
disease: final five-year followup of the SYNTAX trial. Eur Heart J.
Published online 21 May 2014; doi: 10.1093/ eurheartj/ehu213.

63. Stefanini GG, Byrne RA, Windecker S. State of the art :
coronary artery stent– past , present and future. 2017:706–716.

64. Kirtane AJ, Gupta A, Iyengar S, и др. Safety and Efficacy of
Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of
Randomized Trials and Observational Studies. Circulation. 2009;
119(25):3198–3206.

65. Sarno G, Lagerqvist B, Fröbert O, и др. Lower risk of stent
thrombosis and restenosis with unrestricted use of «new-generation»
drug-eluting stents: a report from the nationwide Swedish Coronary
Angiography and Angioplasty Registry (SCAAR). Eur Heart J.
2012;33(5):606–613. doi:10.1093/eurheartj/ehr479.

66.       Stone GW, Rizvi A, Newman W, и др. Everolimus-eluting
versus paclitaxel-eluting stents in coronary artery disease. N Engl J
Med. 2010;362(18):1663–1674. doi:10.1056/NEJMoa0910496.

67.       Kedhi E, Joesoef KS, McFadden E, и др.
Second-generation everolimus-eluting and paclitaxel-eluting stents in
real-life practice (COMPARE): a randomised trial. Lancet.
2010;375(9710):201–209. doi:10.1016/S0140-6736(09)62127-9.

68.       Stefanini GG, Byrne RA, Serruys PW, и др. Biodegradable
polymer drug-eluting stents reduce the risk of stent thrombosis at 4
years in patients undergoing percutaneous coronary intervention: |
pooled analysis of individual patient data from the ISAR-TEST 3,
ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J.
2012;33(10):1214–1222. doi:10.1093/eurheartj/ehs086.

69. E. Braunwald, D.L. Mann, D.P.Zipes, P. Libby, R.O. Bonow.
Braunwald’s Heart Disease: A Textbook Of Cardiovascular Medicine, Tenth
Edition. Elsevier Saunders, 2015. p. 1241.

70. Toyota T, Morimoto T, Shiomi H, Yoshikawa Y, Yaku H,
Yamashita Y, Kimura T.

JACC Cardiovasc Interv. 2017 Jan 9;10(1):27-37.

71. Lipinski MJ, Escarcega RO, Baker NC, Benn HA, Gaglia MA Jr,
Torguson R, Waksman R. JACC Cardiovasc Interv. 2016 Jan 11;9(1):12-24.